After attending the course, participants will understand the molecular targeting approach to the treatment of cancer; become familiar with new therapeutic radiopharmaceuticals and their clinical results to date; and learn about current and future directions of research.
Nuclear Oncology: From Genotype to Phenotype to Targeted Therapy
Mar 13th, 2008Mar 14th, 2008
Baltimore, MD
US
Latest in Home
Out-of-pocket imaging costs may delay needed care
October 15, 2024
New guidelines cover theranostics for brain tumors
October 14, 2024